Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
Authors
Keywords
p38 mitogen activated protein kinase, Alzheimer’s disease, tau, tauopathies, hTau, SB239063, p38 MAPK inhibitor, MW01-10-181SRM, MW181 and MK2 deficiency
Journal
Alzheimers Research & Therapy
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-11-30
DOI
10.1186/s13195-016-0221-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models
- (2015) Saktimayee M. Roy et al. ACS Chemical Neuroscience
- Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain
- (2015) Nicole Maphis et al. BRAIN
- Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
- (2015) Melissa E. Murray et al. BRAIN
- Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling
- (2015) Filip Laco et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- Nemo-like kinase (NLK) negatively regulates NF-kappa B activity through disrupting the interaction of TAK1 with IKKβ
- (2014) Shang-Ze Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Target Engagement Analysis and Link to Pharmacodynamic Endpoint for a Novel Class of CNS-penetrant and Efficacious p38α MAPK Inhibitors
- (2014) Adam D. Bachstetter et al. Journal of Neuroimmune Pharmacology
- Single-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neurons
- (2014) Dennis Janning et al. MOLECULAR BIOLOGY OF THE CELL
- Protein phosphorylation in neurodegeneration: friend or foe?
- (2014) Sandra Tenreiro et al. Frontiers in Molecular Neuroscience
- Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction
- (2013) D. Martin Watterson et al. PLoS One
- Molecular basis of MAP kinase regulation
- (2013) Wolfgang Peti et al. PROTEIN SCIENCE
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Inhibition of Wnt/β-Catenin Signaling by p38 MAP Kinase Inhibitors Is Explained by Cross-Reactivity with Casein Kinase Iδ/ɛ
- (2011) Folkert Verkaar et al. CHEMISTRY & BIOLOGY
- Microglial p38α MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Aβ)
- (2011) Adam D Bachstetter et al. Journal of Neuroinflammation
- Microglial p38α MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFα
- (2011) Bin Xing et al. Molecular Neurodegeneration
- Pathological roles of MAPK signaling pathways in human diseases
- (2010) Eun Kyung Kim et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
- (2010) Lars M. Ittner et al. CELL
- Tau in Alzheimer Disease and Related Tauopathies
- (2010) K. Iqbal et al. Current Alzheimer Research
- The Potential and Limitations of p38MAPK as a Drug Target for the Treatment of Hematological Malignancies
- (2010) Shivashni S. Gaundar et al. CURRENT DRUG TARGETS
- Regulation of Tau Pathology by the Microglial Fractalkine Receptor
- (2010) Kiran Bhaskar et al. NEURON
- Tyrosine phosphorylation of tau accompanies disease progression in transgenic mouse models of tauopathy
- (2010) K. Bhaskar et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
- (2009) M. Polydoro et al. JOURNAL OF NEUROSCIENCE
- The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events
- (2009) Kiran Bhaskar et al. Molecular Neurodegeneration
- Anti-inflammatory treatment with the p38 mitogen-activated protein kinase inhibitor SB239063 is neuroprotective, decreases the number of activated microglia and facilitates neurogenesis in oxygen–glucose-deprived hippocampal slice cultures
- (2008) Maria Strassburger et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- p38 mitogen-activated protein kinase regulates canonical Wnt- -catenin signaling by inactivation of GSK3
- (2008) R. K. Bikkavilli et al. JOURNAL OF CELL SCIENCE
- Selective Activation of p38 Mitogen-Activated Protein Kinase in Dopaminergic Neurons of Substantia Nigra Leads to Nuclear Translocation of p53 in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice
- (2008) S. Karunakaran et al. JOURNAL OF NEUROSCIENCE
- SB203580, a p38 mitogen-activated protein kinase inhibitor, fails to improve functional outcome following a moderate spinal cord injury in rat
- (2008) D.P. Stirling et al. NEUROSCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started